KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 106 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,189 | -20.0% | 84,447 | -38.9% | 0.00% | 0.0% |
| Q1 2023 | $1,487 | +48.8% | 138,180 | +107.2% | 0.00% | +100.0% |
| Q4 2022 | $999 | -99.9% | 66,700 | -45.2% | 0.00% | -50.0% |
| Q3 2022 | $1,564,000 | +199.0% | 121,800 | +125.6% | 0.00% | +100.0% |
| Q2 2022 | $523,000 | -66.8% | 54,000 | -66.0% | 0.00% | -50.0% |
| Q1 2022 | $1,577,000 | -55.8% | 158,700 | -47.7% | 0.00% | -50.0% |
| Q4 2021 | $3,570,000 | +1110.2% | 303,300 | +1716.2% | 0.00% | – |
| Q4 2020 | $295,000 | +22.4% | 16,700 | +6.4% | 0.00% | – |
| Q3 2020 | $241,000 | – | 15,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |